Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.

por Watanabe, J., Sato, Y., Kuramoto, H., Kameya, T.
Publicado 1995

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.

por Yoneda, S., Fujisawa, M., Watanabe, J., Okabe, T., Takaku, F., Homma, T., Yoshida, K.
Publicado 1988

Heat‐killed L actobacillus brevis KB290 attenuates visceral fat accumulation induced by high‐fat diet in mice

por Watanabe, J., Hashimoto, N., Yin, T., Sandagdorj, B., Arakawa, C., Inoue, T., Suzuki, S.
Publicado 2021

Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer

por Fujii, S., Ishibe, A., Ota, M., Watanabe, K., Watanabe, J., Kunisaki, C., Endo, I.
Publicado 2018

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters

por Watanabe, J, Sato, H, Kanai, T, Kamata, Y, Jobo, T, Hata, H, Fujisawa, T, Ohno, E, Kameya, T, Kuramoto, H
Publicado 2002

Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation

por Kawanishi, H, Takahashi, T, Ito, M, Matsui, Y, Watanabe, J, Ito, N, Kamoto, T, Kadowaki, T, Tsujimoto, G, Imoto, I, Inazawa, J, Nishiyama, H, Ogawa, O
Publicado 2007

An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks i...

por Murakami, H., Kurata, T., Onozawa, Y., Watanabe, J., Ono, A., Takahashi, T., Yamamoto, N., Fujisaka, Y., Kiyota, H., Hayashi, H., Tanaka, K., Nakagawa, K., Kuroda, S.
Publicado 2014

Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study

por Oki, E., Watanabe, J., Sato, T., Kagawa, Y., Kuboki, Y., Ikeda, M., Ueno, H., Kato, T., Kusumoto, T., Masuishi, T., Yamaguchi, K., Kanazawa, A., Nishina, T., Uetake, H., Yamanaka, T., Yoshino, T.
Publicado 2021

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies

por Toi, M, Iwata, H, Fujiwara, Y, Ito, Y, Nakamura, S, Tokuda, Y, Taguchi, T, Rai, Y, Aogi, K, Arai, T, Watanabe, J, Wakamatsu, T, Katsura, K, Ellis, C E, Gagnon, R C, Allen, K E, Sasaki, Y, Takashima, S
Publicado 2009

The large area Emulsion Tracker of the CHORUS experiment

por Aoki, S, Dupraz, J P, Fabre, Jean-Paul, Flegel, Wilfried, Hara, T, Ishii, Y, Kawamura, T, Kim, D C, Kurihara, T, Niu, E, Ogawa, S, Shibuya, H, Song, J S, Van Beek, G, Vilain, P, Watanabe, J, Wilquet, G, Yoon, C S
Publicado 2001

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7

por Takahashi, T., Yamazaki, K., Oki, E., Shiozawa, M., Mitsugi, K., Makiyama, A., Nakamura, M., Ojima, H., Kagawa, Y., Matsuhashi, N., Okuda, H., Asayama, M., Yuasa, Y., Shimada, Y., Manaka, D., Watanabe, J., Oba, K., Yoshino, T., Yoshida, K., Maehara, Y.
Publicado 2021

S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the p...

por Watanabe, J., Sasaki, S., Kusumoto, T., Sakamoto, Y., Yoshida, K., Tomita, N., Maeda, A., Teshima, J., Yokota, M., Tanaka, C., Yamauchi, J., Uetake, H., Itabashi, M., Takahashi, K., Baba, H., Kotake, K., Boku, N., Aiba, K., Morita, S., Takenaka, N., Sugihara, K.
Publicado 2021